BDBM50089567 CHEMBL35857::N-[(E)-1-(4-Chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide

SMILES CN(C(Cc1ccc(Cl)cc1)\C=C\C(=O)NC1CCCCNC1=O)C(=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F

InChI Key InChIKey=ATMHFQDWDFHUDF-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50089567   

TargetSubstance-P receptor(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089567(N-[(E)-1-(4-Chloro-benzyl)-3-(2-oxo-azepan-3-ylcar...)
Affinity DataIC50: 0.760nMAssay Description:In vitro inhibition of [3H]Sar9-substance P binding to Tachykinin receptor 1 in bovine retinal membranesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSubstance-K receptor(Human)
Novartis Pharma

Curated by ChEMBL
LigandPNGBDBM50089567(N-[(E)-1-(4-Chloro-benzyl)-3-(2-oxo-azepan-3-ylcar...)
Affinity DataIC50: 55nMAssay Description:In vitro inhibition of [125I]NKA binding to transfected Chinese hamster ovary cells (CHO cells) expressing recombinant human Tachykinin receptor 2More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed